Cargando…
First‐in‐human trial assessing the pharmacokinetic‐pharmacodynamic profile of a novel recombinant human chorionic gonadotropin in healthy women and men of reproductive age
The purpose of this first‐in‐human trial was to examine the safety, pharmacokinetics (PK), and pharmacodynamics (PD) of a novel recombinant human chorionic gonadotropin (rhCG; FE 999302, choriogonadotropin beta) to support its clinical development for various therapeutic indications. The single and...
Autores principales: | Broksø Kyhl, Lars‐Erik, Hesse, Christiane, Larsson, Per, Bruzelius, Katharina, Mannaerts, Bernadette |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301557/ https://www.ncbi.nlm.nih.gov/pubmed/33982429 http://dx.doi.org/10.1111/cts.13037 |
Ejemplares similares
-
Single‐dose pharmacokinetic study comparing the pharmacokinetics of recombinant human chorionic gonadotropin in healthy Japanese and Caucasian women and recombinant human chorionic gonadotropin and urinary human chorionic gonadotropin in healthy Japanese women
por: Bagchus, Wilhelmina, et al.
Publicado: (2017) -
Randomized Pharmacokinetic Study of a Highly Purified Human Chorionic Gonadotropin and of a Recombinant Human Chorionic Gonadotropin Following Single Subcutaneous Administration in Healthy Women
por: Radicioni, Milko, et al.
Publicado: (2022) -
Comparative Pharmacokinetics, Bioequivalence and Safety Study of Two Recombinant Human Chorionic Gonadotropin Injections in Healthy Chinese Subjects
por: Wang, Jin, et al.
Publicado: (2020) -
IMMUNOHISTOCHEMICAL LOCALIZATION OF HUMAN CHORIONIC GONADOTROPIN
por: Midgley, A. R., et al.
Publicado: (1962) -
Human Chorionic Gonadotropin and Breast Cancer
por: Schüler-Toprak, Susanne, et al.
Publicado: (2017)